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Objective: Health care databases are a valuable source for epidemiological research in 
respiratory diseases if diagnoses are valid. We validated the International Classification of Dis-
eases, 10th revision (ICD-10) diagnosis of pleural empyema in the Danish National Registry 
of Patients (DNRP).
Methods: We randomly selected hospitalized patients registered in the DNRP with a discharge 
diagnosis of pleural empyema between 1995 and 2009 in the North Denmark Region. We retrieved 
and reviewed medical records and estimated the positive predictive value (PPV) of the empy-
ema diagnosis. Analyses were stratified by study period, hospital type (referral versus district), 
department type (pulmonary medicine or thoracic surgery versus other), cause of empyema 
(medical, surgical, or traumatic), and age group. To assess changes over time, we included 
chi-square tests for linear trend.
Results: We retrieved the medical records of 224/225 sampled patients with empyema (99.6%). 
Of those, 182 were classified as being definite cases, and 21 were probable cases, yielding a 
PPV of 90.6% (95% confidence interval [CI]: 86.0–94.1). The PPV decreased from 95.7% in 
patients aged 15–39 years to 87.5% in patients aged 80 years and over but was uniformly high 
regardless of study period, hospital or department type, or cause of empyema.
Conclusion: Our finding of a high overall PPV indicated good agreement between ICD-10 
codes for pleural empyema and medical records. Registry-based discharge codes may be a 
suitable source of data on pleural empyema for epidemiological research.
Keywords: pneumonia, positive predictive value, validation, International Classification of 
Disease Codes, empyema
Introduction
Pleural empyema is a serious infection characterized by the accumulation of pus in 
the pleural space.1 In the United States, 65,000 patients suffer from empyema each 
year, with 30-day mortality up to 15% and an estimated hospital cost of $500 million 
due to prolonged hospitalizations and multiple invasive procedures.2–5 The empyema 
usually develops as a complication of pneumonia (40%–60% of all empyemas), thoracic 
surgery (20%), or trauma (4%–10%).6 Less commonly, empyema can develop as a 
result of esophageal rupture and subdiaphragmatic spread.
Many of the studies addressing risk factors and outcome of empyema rely on 
hospital discharge diagnosis codes recorded in administrative health care databases.7–9 
Use of these databases for epidemiological research can be a cost-effective way 
of collecting data on empyema.10–12 The large size of many databases offers the 
potential for precise estimates of effect and for studying rare exposures or outcomes. Clinical Epidemiology 2011:3 submit your manuscript | www.dovepress.com
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At the same time, the risk of some biases, such as recall 
bias and nonresponse, is reduced. On the other hand, the 
researchers have no control of data selection and quality, 
and the usability of these databases is therefore highly reliant 
on the validity of the registered data.10–12 Thus, to draw valid 
inferences from database studies of pleural empyema, the 
validity of the diagnosis needs to be quantified.11,13
To our knowledge, no study has validated pleural empy-
ema diagnosis in hospital registries. We therefore examined 
the positive predictive value (PPV) of empyema discharge 
diagnosis in the population-based Danish National Patient 
Registry (DNRP) using data from medical record reviews 
as the reference. In addition, we determined whether the 
validity of the empyema diagnosis varied by calendar 
period, hospital or department type, cause of empyema, or 
patient age.
Materials and methods
Denmark has 5.3 million inhabitants, and the National Health 
Service provides universal tax-supported health care. Since 
1968, a unique 10-digit civil registry number (CPR number) 
has been assigned to all Danish residents at birth or emigration 
by the Danish Civil Registry System.14 In all Danish registries, 
patients are identified by their CPR-number. We therefore 
linked national data on hospital diagnoses and medical records 
using the CPR number and identified patients diagnosed with 
pleural empyema between 1995 and 2009 residing in the North 
Denmark Region (with a population of 579,741 inhabitants 
or ∼10% of the population of Denmark in 200915).
The DnrP
The DNRP tracks each hospital admission in Denmark since 
1977, recording dates of admission and discharge, and up 
to 20 discharge diagnoses. The registry covers 99.4% of 
all discharge records from Danish hospitals.16 Diagnoses 
are coded by physicians using the Danish version of the 
International Classification of Diseases, 8th revision (ICD-8) 
(1977–1993) and 10th revision (ICD-10) (1994 onward). 
Since 1995, outpatient contacts and visits to the emergency 
room have been recorded in addition to the hospital stays.
Identification of coded pleural  
empyema cases
Using the DNRP, we identified all discharges between 1995 
and 2009 associated with a primary or secondary diagnosis 
of empyema (ICD-10 codes J86.0 Pyothorax with fistula and 
J86.9 Pyothorax without fistula). We did not evaluate the 
coding of tuberculous empyema (ICD-10 code A15.6) because 
we consider these cases to constitute a distinct disease group 
that is categorized separately in the ICD-10 system; that is, 
under A15 “Respiratory tuberculosis, bacteriologically and 
histologically confirmed”.17 Because we were interested in first 
incident episodes of empyema, we removed all hospitalizations 
for any recurrent episode of empyema during 1995–2009, and 
patients who had been hospitalized for empyema between 
1977 and 1994 (ICD-8 code 510 Empyema pleurae). We also 
removed pediatric patients ,15 years of age.
Medical record validation
To validate the diagnoses of empyema identified in the DNRP, 
we randomly selected 15 patients in each calendar year using 
the SAS RANUNI function (SAS Institute, Cary, NC). We 
then used CPR numbers to identify the corresponding medical 
records. We confined the review to the North Denmark 
Region, as data quality is considered uniform in the hospital 
discharge registries.13 The records were reviewed by one of 
two reviewers (MS or JBK), who assessed all the available 
information, including written radiology reports and results 
from laboratory tests. The actual imaging films were not 
reinterpreted, and the available information was in most cases 
identical with the information available to the physician at the 
time of discharge. All cases with an uncertain diagnosis based 
on the available information were discussed, and diagnoses 
were made according to consensus.
Based on the available information, we classified the 
empyema cases as either definite, probable, or no evidence of 
empyema. Definite empyema was defined by frank pus aspirated 
from the pleural space, a positive Gram stain/subculture for 
pathogenic microorganisms in the pleural fluid, and/or an 
autopsy diagnosis of empyema.1,6,18,19 Patients with clinical 
symptoms suggestive of empyema in association with 
compatible radiographic features (eg, pleural thickening, 
loculated and/or septated pleural effusions6,20) who did not 
meet the criteria for definite empyema were classified as having 
probable empyema. We ruled out empyema when results of 
diagnostic tests were negative, or if no tests were performed 
because symptoms had disappeared, or were explained by 
another disease. We further categorized the most probable 
cause of the patients’ empyemas as: previous surgery (patients 
who had an operation involving the thoracic cavity before 
their empyema), trauma, esophageal rupture, or any medical 
cause (patients who did not have thoracic surgery, trauma, or 
esophageal rupture and were presumed to have a medical cause 
for their empyema, most frequently pneumonia).
Statistical analysis
Our study outcome was the PPV of an empyema diagnosis, 
defined as the proportion of patients with an empyema Clinical Epidemiology 2011:3 submit your manuscript | www.dovepress.com
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diagnosis in the DNRP who had definite or probable 
empyema according to their medical record. We calculated 
the PPV with 95% confidence intervals (CIs). The PPV was 
calculated for the whole study population and stratified by 
calendar period (1995–1999, 2000–2004, and 2005–2009). 
This stratification was done to examine whether the validity 
differed over time and included a chi-square test for linear 
trend. In addition, PPVs were calculated according to hospital 
type (referral versus district), department type (pulmonary 
medicine or thoracic surgery versus other departments), 
cause of empyema, and age group (15–39, 40–64, 65–79, 
80 years and older).
We analyzed the data with Stata Software (v. 11.1; Stata 
Corp. College Station, TX). The study was approved by the 
  Danish Data Protection Agency (Journal no. 2010-41-4969).
Results
Description of study population
From 509 adult patients in Northern Denmark registered with 
empyema in the DNRP between 1995 and 2009, we randomly 
selected 225 cases for this validation study. We excluded 
one patient who was transferred to a hospital outside the region 
with a suspected empyema. Of the remaining 224 patients with 
available medical records, we classified 182 (81.3%) as being 
definite empyema cases. Twenty-one patients did not meet the 
criteria for definite empyema and were classified as probable 
cases. Among the remaining 21 patients whose empyema 
diagnosis was rejected, 19 patients had other pulmonary 
disorders; one had a pulmonary abscess, one had pulmonary 
tuberculosis, one had sarcoidosis, two had emphysema, eight 
had pneumonia, one had chylothorax, one had multiple rib 
fractures, one had chronic sequelae after previous pneumonia, 
and three had pulmonary cancer. The two remaining patients 
had severe muscle dystrophia and surgical site infection, 
respectively. Table 1 shows demographic and diagnostic 
characteristics of patients registered in the DNRP according 
to whether they had definite, probable, or no empyema. 
Characteristics of pleural fluid were left undocumented in the 
medical record in ten patients classified as having definite or 
probable empyema, three of which died shortly after admission. 
Among the 191 patients with definite or probable empyema 
who had their pleural fluid microbiologically evaluated, 
the proportion of positive samples was 61.8% (118/191). 
Seven of the 12 definite or probable empyema cases without 
microbiological evaluation died shortly after admission.
Validation of empyema diagnosis
The overall PPV including definite and probable empyema 
hospitalizations was 90.6% (95% CI: 86.0–94.1) and 81.3% 
(95% CI: 81.3–86.1) when focusing only on definite cases. 
PPVs of empyema diagnosed in 1995–1999, 2000–2004, 
and 2005–2009 were 90.7% (95% CI: 81.7–96.2), 94.6% 
(95% CI: 86.7–98.5), and 86.7% (95% CI: 76.8–93.4), 
respectively, indicating that no major changes in empyema 
coding validity occurred over the 15-year study period 
(P-value for trend = 0.40). The PPVs in different strata 
of calendar period, hospital type, department type, and 
cause of empyema showed only slight differences from the 
overall PPV. However, the PPV appeared to decrease with 
increasing age; that is, from 95.7% (95% CI: 78.1–99.9) in 
patients aged 15–39 years to 87.5% (95% CI: 67.6–97.3) in 
patients aged 80 years and over (P-value for trend , 0.001) 
(Table 2).
Table  1  Descriptive  and  diagnostic  characteristics  of  the 
224  patients  with  pleural  empyema  registered  in  the  Danish 
national registry of Patients, 1995–2009
Characteristic Diagnosis of empyema
Definite,  
n (%)
Probable,  
n (%)
Rejected,   
n (%)
Total 182 (81.3) 21 (9.4) 21 (9.4)
Age group
  15–39 19 (10.4) 3 (14.3) 1 (4.8)
  40–64 76 (41.8) 11 (52.4) 8 (38.1)
  65–79 69 (37.9) 4 (19.1) 9 (42.9)
  80 and older 18 (9.9) 3 (14.3) 3 (14.3)
Sex
  Male 125 (68.7) 16 (76.2) 14 (66.7)
  Female 57 (31.1) 5 (23.8) 7 (33.3)
Chronic obstructive  
pulmonary disease
22 (12.1) 0 5 (23.8)
Bronchial asthma  5 (2.8) 1 (4.8) 4 (19.1)
Cause of empyema
  Medical 144 (79.1) 19 (90.5) 16 (76.2)
  Surgical 24 (13.2) 0 4 (19.1)
  Esophageal rupture 3 (1.7) 2 (9.5) 0
  Trauma 11 (6.0) 0 1 (4.8)
Diagnostic criteria
Autopsy diagnosis  
of empyema
4 (2.2) – –
Pus in the pleural space
  Yes 171 (94.0) – –
  no  5 (2.8) 17 (81.0) 18 (85.7)
  no information 6 (3.3) 4 (19.1) 3 (14.3)
gram stain or culture  
of pleural fluid
  Positive 118 (64.8) – –
  negative 57 (31.3) 16 (76.2) 13 (61.9)
    no microbiological  
evaluation
7 (3.9) 5 (23.8) 8 (38.1)
radiographic features  
of empyema
  Yes 174 (95.6) 21 (100.0) 4 (19.1)
  no  5 (2.8) 0 15 (71.4)
  no information 3 (1.7) 0 2 (9.5)Clinical Epidemiology 2011:3 submit your manuscript | www.dovepress.com
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Discussion
Our finding of a high overall PPV indicated good agreement 
between ICD-10 codes for pleural empyema and medical 
records. In addition, we detected little variation in the PPV 
by calendar period, hospital type, department type, or cause. 
However, PPV was slightly higher in younger age groups 
than in elderly patients.
Although we examined only a segment of the Danish 
national population, the results can be assumed to be 
generalizable, thanks to the uniform structure of record 
keeping and the universal nature of the health care system 
across Denmark. However, a number of limitations need to be 
considered in the interpretation of the results. First, we only 
examined one dimension of the validity: the predictive value 
of a positive registration of empyema. The optimal validation 
study would also examine sensitivity and specificity,10 but 
since no other data source with empyema exists, only the 
predictive value could be estimated. Second, most of the 
medical records were evaluated by one reviewer. However, 
any cases with an uncertain diagnosis were evaluated by both 
reviewers independently. Thereafter, final diagnoses were 
made according to consensus. The reviewers were not blinded 
to the registered discharge diagnosis codes, and blinding is 
usually recommended in diagnostic studies.21 However, since 
the result of the “test under study” (the register diagnosis) 
was by definition given for all the examined patients (as only 
patients who had a diagnosis were included), it is unlikely that 
lack of blinding of the reviewers would have influenced the 
PPV in general. Third, pleural effusions represent a spectrum 
of inflammatory fluid collections that ranges from transudative 
effusion to empyema, and the differentiation of this spectrum 
into patients with empyema and those without is somewhat 
arbitrary.1,6 Studies have shown that neither radiography, 
ultrasound, nor computed tomography can reliably identify 
the stage of pleural disease in adult patients with effusions 
and empyema.22,23 Although we carefully evaluated the 
reported clinical and radiographic findings, we may therefore 
have overestimated the PPV among patients with probable 
empyema. Finally, we do not know to what extent our findings 
can be extrapolated to other places, where the prevalence of 
empyema and the diagnostic strategy may be different.
Whether the data quality documented in our study is 
sufficient for registry-based studies depends on the proposed 
research questions and the study design used.10 If databases 
such as the DNRP are used to assess changes in incidence of 
empyema over time, the PPV must remain stable over time to 
obtain valid estimates.24 We found a slight variation in PPV by 
study period but there was not a significant linear trend over the 
15-year period of our study. Thus, the increasing availability 
of advanced diagnostic tools, including computed tomography 
and magnetic resonance imaging, between 1995 and 2009 
apparently did not improve the quality of diagnostic coding. 
We do not know whether there might have been any substantial 
time trends in the data quality before 1995. In analytical studies, 
inaccurate or missing data tend to bias the association toward 
the null hypothesis rather than to cause spurious associations, 
Table 2 Validity of pleural empyema diagnosis
Total no. of cases No. definite cases no. probable cases PPV (%) 95% CI
All  224 182 21 90.6 86.0–94.1
Period
  1995–1999 75 63 5 90.7 81.7–96.2
  2000–2004 74 65 5 94.6 86.7–98.5
  2005–2009 75 54 11 86.7 76.8–93.4
hospital type
  referral hospital  139 117 10 91.4 85.4–95.5
  District hospital 85 65 11 89.4 80.8–95.0
Department type
    Pulmonary medicine  
or thoracic surgery
101 85 7 91.1 83.8–95.8
  Other 123 97 14 90.2 83.6–94.9
Cause of empyema
  Medical 179 144 19 91.1 85.9–94.8
  Surgical incl. esophageal rupture 33 27 2 87.9 77.8–96.6
  Trauma 12 11 0 91.7 61.5–99.8
Age group (years)
  15–39 23 19 3 95.7 78.1–99.9
  40–64 95 76 11 91.6 84.1–96.3
  65–79 82 69 4 89.2 80.2–94.9
  80 and older 24 18 3 87.5 67.6–97.3
Abbreviations: PPV, positive predictive value; CI, confidence interval.Clinical Epidemiology
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as long as the sensitivity and specificity are similar in the 
compared groups.10 At the same time, if empyema is used as 
the outcome of interest, imperfect sensitivity, no matter how 
low, is not expected to bias relative measures of association as 
long as the specificity is 100%.25 We have shown that empyema 
cases that are registered largely represent true instances of this 
event. If the misclassification of empyema is associated with 
the examined exposure of interest, however, the risk estimates 
may be biased, both toward and away from the null, depending 
on the direction of the association.
Denmark and a few other places in the world are 
privileged by having a broad network of population-based 
registries,9,14,18,26 which enables use of routinely collected 
data to rapidly assemble large cohorts for epidemiological 
studies, including that of pleural empyema. The high PPV 
estimated in this study indicates a low false-positive number 
of empyema cases in the DNRP, suggesting that the DNRP 
is a valid source for identifying cases of empyema for 
epidemiological research.
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